BioNTech has agreed to pay UK drugmaker GSK royalties on its Covid-19 and influenza vaccines as part of a patent settlement with CureVac, in a deal that allows the biotech to move forward with the ...

Robert F. Kennedy Jr., the HHS Secretary of the US, despite a long history of the contray, now often pretends to be not against vaccinations. Yet, his recent actions depict an entirely different ...

The Trump administration says it is pulling half a billion dollars from U.S. government-funded research projects to create ...

The pharma giant will also receive a 1% royalty on future U.S. sales of influenza, Covid-19 and other related combination ...

Germany's CureVac and Britain's GSK have settled a years-long patent dispute with Pfizer and its partner BioNTech over the ...

The vaccine used in this trial, known as AHEAD-MERIT (BNT113-01), will help the immune system recognise and kill cancer cells ...

U.S. Health Secretary Robert F. Kennedy Jr. incorrectly argued mRNA vaccines are ineffective to justify the Department of ...

Health Secretary Robert F. Kennedy Jr. announced plans on Tuesday to cancel 22 mRNA vaccine development contracts totaling nearly $500 million. The move follows a “comprehensive review of mRNA-related ...

German drugmaker CureVac and GSK reached an agreement with BioNTech and Pfizer on Thursday to resolve a years-long patent ...

The U.S. Department of Health and Human Services announced a significant shift in vaccine funding, spearheaded by Health ...

The U.S. Department of Health and Human Services announced a significant shift in vaccine funding, spearheaded by Health ...

In Danes over age 65, the vaccine effectiveness of the JN.1-based mRNA boosters reached 70-85% against COVID-related hospitalization and 76-96% against COVID-associated death. Despite the shift away ...